Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wood BioConsulting is a specialized regulatory and clinical operations consulting firm serving the biotechnology and pharmaceutical industries. Founded and led by Dr. Erik Wood, the firm provides strategic guidance on global regulatory pathways, clinical trial design, and submission management. The company leverages Dr. Wood's extensive executive experience at major biotech firms, including BioMarin and Ultragenyx, to support clients in navigating complex FDA and EMA requirements. Wood BioConsulting primarily focuses on rare diseases, orphan drugs, and advanced therapeutic modalities such as gene and enzyme replacement therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr Erik Wood.